相关实验视频
Updated: Jan 15, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.4K
双MA-DTI:一个双向的Mamba-Attention混合框架,用于增强药物向相互作用预测
Youyuan Shui1, Xuewen Ge1, Chen Cao2
1Department of Medical Informatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, 101 Longmian Avenue, Nanjing, 211166, Jiangsu, China.
BMC biology
|October 15, 2025
概括
本研究介绍了BiMA-DTI,这是一个新的计算框架,用于使用先进的深度学习来预测药物向相互作用 (DTI). 通过整合Mamba和注意力机制来提高DTI预测精度,BiMA-DTI提高了药物发现效率.
科学领域:
- 计算生物学是一种计算生物学.
- 药物发现 药物发现
- 生物信息学是一种生物信息学.
背景情况:
- 药物向相互作用 (DTI) 的预测对于加速药物发现至关重要.
- 传统的DTI预测实验方法资源密集且耗时.
- 计算方法,特别是机器学习和深度学习,提供了高效的替代方案.
研究的目的:
- 引入BiMA-DTI框架,以提高药物向相互作用的预测.
- 利用Mamba的国家空间模型 (SSM) 和多头注意力机制的优势.
- 开发一个强大的计算工具来识别潜在的药物候选者.
主要方法:
- 开发了BiMA-DTI框架,将Mamba (SSM) 集成到多个头的注意力.
- 为多式输入处理 (蛋白质序列,SMILES,分子图) 设计了一种混合的Mamba-Attention Network (MAN) 和Graph Mamba Network (GMN).
- 实施了两步加权的融合策略,将序列和基于图形的特征结合起来,然后通过完全连接的网络进行预测.
主要成果:
- BiMA-DTI有效地处理使用Mamba的长序列和使用注意力的短序列.
- 与基准数据集上的最先进方法相比,该框架实现了更高的性能.
- 废弃研究证实了建筑设计的有效性和概括能力.
结论:
- BiMA-DTI显示出作为一种强大的新药发现工具的巨大潜力.
- 实验结果和案例研究验证了BiMA-DTI在DTI预测中的可靠性和准确性.
- 可视化研究提供了对潜在的生物机制的解释性.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drug-Receptor Interaction: Antagonist
4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Drug-Receptor Interactions
7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K

